
|Videos|March 27, 2017
The Long-Term Impact of Biosimilars
Author(s)Lauren Santye, Assistant Editor
Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses how biosimilars could impact specialty pharmacy into the immediate future.
Advertisement
Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses how biosimilars could impact specialty pharmacy into the immediate future.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Polycystic Ovary Syndrome Undergoes Name Change: Polyendocrine Metabolic Ovarian Syndrome
2
Amid Mounting Pressure, FDA Commissioner Marty Makary Resigns
3
GLP-1 Receptor Agonists Linked to Improved Survival Outcomes in Breast Cancer
4
Sonrotoclax Approval Delivers a Long-Awaited New Option for Relapsed or Refractory Mantle Cell Lymphoma
5


































































































































